Abstract
We analysed dynamic mutation profiles of next-generation sequencing (NGS) T790M+ advanced non-small cell lung cancer (NSCLC) patients from an open-label, multicentre study (ADELOS, NCT02997501) in China.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have